Cargando…
P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH
Autores principales: | Griffin, Morag, Humphreys, Jane, Philpot, Edward, Jason Cummings, W., Pullman, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430637/ http://dx.doi.org/10.1097/01.HS9.0000970052.45858.28 |
Ejemplares similares
-
Characteristics of Taiwanese patients of PNH in the international PNH registry
por: Chou, Wen-Chien, et al.
Publicado: (2016) -
Polymorphisms in the MASP1 Gene Are Associated with Serum Levels of MASP-1, MASP-3, and MAp44
por: Gytz Ammitzbøll, Christian, et al.
Publicado: (2013) -
Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)
por: Lam, Wing, et al.
Publicado: (2018) -
MAp19, the alternative splice product of the MASP2 gene
por: Degn, Søren E., et al.
Publicado: (2011) -
787. Improving ED Sepsis Care
por: Sloan, William A, et al.
Publicado: (2019)